Cargando…
Early outcome of a 31‐gene expression profile test in 86 AJCC stage IB‐II melanoma patients. A prospective multicentre cohort study
BACKGROUND: The clinical and pathological features of primary melanoma are not sufficiently sensitive to accurately predict which patients are at a greater risk of relapse. Recently, a 31‐gene expression profile (DecisionDx‐Melanoma) test has shown promising results. OBJECTIVES: To evaluate the earl...
Autores principales: | Podlipnik, S., Carrera, C., Boada, A., Richarz, N.A., López‐Estebaranz, J.L., Pinedo‐Moraleda, F., Elosua‐González, M., Martín‐González, M.M., Carrillo‐Gijón, R., Redondo, P., Moreno, E., Malvehy, J., Puig, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483866/ https://www.ncbi.nlm.nih.gov/pubmed/30702163 http://dx.doi.org/10.1111/jdv.15454 |
Ejemplares similares
-
Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study
por: Podlipnik, Sebastian, et al.
Publicado: (2022) -
Pseudonits or Hair Casts
por: Lukoviek, Vania, et al.
Publicado: (2020) -
When Seborrheic Keratosis Is Wearing a Mask
por: Sousa, Cristina, et al.
Publicado: (2020) -
Minutes of the meeting on 31 1 86
por: Forti, F
Publicado: (1986) -
Inherited MC1R variants in patients with melanoma are associated with better survival in women
por: Lira, F.E., et al.
Publicado: (2019)